文献速递甲状腺疾病

甲状腺功能、心血管危险因素与动脉粥样硬化性心血管疾病事件:社区动脉粥样硬化风险(ARIC)研究

Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

在ARIC研究中,对11359名无既往心梗、卒中或心衰的黑人与白人受试者,检测1990-1992年储存血清的促甲状腺激素、游离甲状腺素和总三碘甲状腺原氨酸,横断面分析甲状腺功能与心血管危险因素的关系,并随访至2014年12月31日观察心血管事件。结果显示甲状腺功能与血脂的关联强于血压或血糖指标,但轻度化学性甲状腺功能减退时低密度脂蛋白胆固醇的差异幅度较小,且不同甲状腺功能组的冠心病与卒中结局相似。

要点

  • 甲状腺功能与血脂的关联强于血压或血糖指标。
  • 中度/重度化学性甲状腺功能减退者低密度脂蛋白胆固醇平均校正差异为+15.1 mg/dL。
  • 轻度化学性甲状腺功能减退者低密度脂蛋白胆固醇平均校正差异为+3.2 mg/dL。

核心结论

  • 甲状腺功能减退与高脂血症相关,但轻度化学性甲状腺功能减退时幅度较小,且不同甲状腺功能组的心血管结局相似。

研究设计与样本

  • 在社区动脉粥样硬化风险(ARIC)研究中,检测1990-1992年原始采集的储存血清样本中的促甲状腺激素、游离甲状腺素和总三碘甲状腺原氨酸浓度。
  • 采用多变量线性回归评估甲状腺功能与心血管危险因素的横断面关联,采用Cox回归评估与心血管事件的前瞻性关联,随访至2014年12月31日。
  • 研究对象为美国无既往心肌梗死、卒中或心力衰竭的黑人与白人男性和女性,共11359人(57±6岁,58%为女性)。

主要发现

  • 相对于甲状腺功能正常者,中度/重度化学性甲状腺功能减退者低密度脂蛋白胆固醇平均校正差异为+15.1(95%置信区间:10.5至19.7)mg/dL,轻度化学性甲状腺功能减退者为+3.2(95%置信区间:0.0至6.4)mg/dL,甲状腺功能亢进者呈相反模式。
  • 甘油三酯和非高密度脂蛋白胆固醇也可见类似差异。
  • 中位随访22.5年期间发生1102例心肌梗死和838例卒中,基线甲状腺功能组间及按三碘甲状腺原氨酸浓度分析的结局相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Cardiovascular outcomes in mild thyroid dysfunction (treatment controversial) and moderate or severe dysfunction (treatment standard) remain uncertain. OBJECTIVE: To examine cross-sectional and prospective associations of thyroid function with cardiovascular risk factors and events. DESIGN: In the Atherosclerosis Risk in Communities Study, we measured concentrations of thyrotropin, free thyroxine, and total triiodothyronine (T3) in stored serum samples originally collected in 1990-1992. We used multivariable linear regression to assess cross-sectional associations of thyroid function with cardiovascular risk factors and Cox regression to assess prospective associations with cardiovascular events. Follow-up occurred through 31 December 2014. SETTING: General community. PARTICIPANTS: Black and white men and women from the United States, without prior myocardial infarction (MI), stroke, or heart failure. MAIN OUTCOMES AND MEASURES: Cross-sectional outcomes were blood pressure, glycemic markers, and blood lipids. Prospective outcomes were adjudicated fatal and nonfatal MI and stroke. RESULTS: Among 11,359 participants (57 ± 6 years, 58% women), thyroid function was more strongly associated with blood lipids than blood pressure or glycemic measures. Mean adjusted differences in low-density lipoprotein cholesterol were +15.1 (95% confidence interval: 10.5 to 19.7) and +3.2 (0.0 to 6.4) mg/dL in those with moderate/severe and mild chemical hypothyroidism, relative to euthyroidism; an opposite pattern was seen in hyperthyroidism. Similar differences were seen in triglycerides and non-high-density lipoprotein cholesterol. With a 22.5-year median follow-up, 1102 MIs and 838 strokes occurred, with similar outcomes among baseline thyroid function groups and by T3 concentrations. CONCLUSIONS: Hypothyroidism is associated with hyperlipidemia, but the magnitude is small in mild chemical hypothyroidism, and cardiovascular outcomes are similar between thyroid function groups.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Martin SS, Daya N, Lutsey PL, et al. Thyroid Function, Cardiovascular Risk Factors, and Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study. J Clin Endocrinol Metab. 2017. PMID: 28605456. doi:10.1210/jc.2017-00986

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。